Agamree (vamorolone) - Santhera
Expanding vamorolone treatment access for Canadians with Duchenne muscular dystrophy. (PubMed, Can J Neurol Sci) - Jul 14, 2026 - No abstract available 
Journal • Duchenne Muscular Dystrophy • Genetic Disorders • Muscular Dystrophy
http://www.ncbi.nlm.nih.gov/pubmed/42438401
 
Anne Marie Sbrocchi; Craig Campbell; Hanns Lochmüller; Hernan Gonorazky; Hugh J McMillan; Jean K Mah; Judy Wiles; Kasha Mitton; Kathryn Selby; Leanne Ward; Nicola Worsfold
 
Jul 14, 2026
 
Prev Next